Biopharma Healthcare Provider Pharmaceutical manufacturing 
Clarivate
MARCH 14, 2024
Nitrosamines have garnered significant attention from the pharmaceutical industry due to their detection in commonly prescribed medications for conditions like type 2 diabetes, high blood pressure, and heartburn. [1] Manufacturers, healthcare providers, and consumers alike face the need to quickly adapt.
European Pharmaceutical Review
DECEMBER 21, 2022
The healthcare industry is successful in innovating new treatment paradigms ranging from small molecular to biological therapeutics to personalised medicines. Defossilization of pharmaceutical manufacturing. Biopharma successful in achieving climate-related goals, report finds … . 33, February 2022, 100586.
Expert insights. Personalized for you.
52 
Let's personalize your content